Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CL<sup>pro</sup>
Journal of biomolecular structure and dynamics/Journal of biomolecular structure & dynamics